Lorenzo Spagnuolo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lorenzo Spagnuolo has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Anne Oberson
Chair of Pharmacology Department of Medicine Faculty of Science University of Fribourg Fribourg Switzerland
1 shared publication- Carole Bourquin
School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland
1 shared publication Christian Hotz
Chair of Pharmacology Department of Medicine Faculty of Science University of Fribourg Fribourg Switzerland
1 shared publicationInès Mottas
Chair of Pharmacology Department of Medicine Faculty of Science University of Fribourg Fribourg Switzerland
1 shared publicationJerome Widmer
Chair of Pharmacology Department of Medicine Faculty of Science University of Fribourg Fribourg Switzerland
1 shared publicationMarco E. Bianchi
Division of Genetics and Cell Biology San Raffaele University and Scientific Institute Milan Italy
1 shared publication
Latest Publications
- Open Access
- 1 June 2021
- Published by Wiley in European Journal of Immunology
- Vol. 51 (8) , 1980-1991
HMGB1 promotes CXCL12‐dependent egress of murine B cells from Peyer's patches in homeostasis
High mobility group box-1 protein (HMGB1) is an alarmin that, once released, promotes inflammatory responses, alone and as a complex with the chemokine CXCL12. Here we report that the HMGB1-CXCL12 complex plays an essential role also in homeostasis by controlling the migration of B lymphocytes. We show that extracellular HMGB1 is critical for the CXCL12-dependent egress of B cells from the Peyer's patches (PP). This promigratory function of the complex was restricted to the PPs, since HMGB1 was not required for B-cell migratory processes in other locations. Accordingly, we detected higher constitutive levels of the HMGB1-CXCL12 complex in PPs than in other lymphoid organs. HMGB1-CXCL12 in vivo inhibition was associated with a reduced basal IgA production in the gut. Collectively, our results demonstrate a role for the HMGB1-CXCL12 complex in orchestrating B-cell trafficking in homeostasis, and provide a novel target to control lymphocyte migration in mucosal immunity. This article is protected by copyright. All rights reserved
- 1 June 2021
- Published by Wiley in European Journal of Immunology
- Vol. 51 (8) , 1980-1991
Open AccessHMGB1 promotes CXCL12‐dependent egress of murine B cells from Peyer's patches in homeostasis
High mobility group box-1 protein (HMGB1) is an alarmin that, once released, promotes inflammatory responses, alone and as a complex with the chemokine CXCL12. Here we report that the HMGB1-CXCL12 complex plays an essential role also in homeostasis by controlling the migration of B lymphocytes. We show that extracellular HMGB1 is critical for the CXCL12-dependent egress of B cells from the Peyer's patches (PP). This promigratory function of the complex was restricted to the PPs, since HMGB1 was not required for B-cell migratory processes in other locations. Accordingly, we detected higher constitutive levels of the HMGB1-CXCL12 complex in PPs than in other lymphoid organs. HMGB1-CXCL12 in vivo inhibition was associated with a reduced basal IgA production in the gut. Collectively, our results demonstrate a role for the HMGB1-CXCL12 complex in orchestrating B-cell trafficking in homeostasis, and provide a novel target to control lymphocyte migration in mucosal immunity. This article is protected by copyright. All rights reserved